Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence a

  title={Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence a},
  author={Deborah C. Mash and Craig A. Kovera and Billy E. Buck and M D Norenberg and Paul Shapshak and William Lee Hearn and Juan R. Sanchez-Ramos},
  journal={Annals of the New York Academy of Sciences},
ABSTRACT: The potential for deriving new psychotherapeutic medications from natural sources has led to renewed interest in rain forest plants as a source of lead compounds for the development of antiaddiction medications. Ibogaine is an indole alkaloid found in the roots of Tabernanthe iboga (Apocynaceae family), a rain forest shrub that is native to equatorial Africa. Ibogaine is used by indigenous peoples in low doses to combat fatigue, hunger and in higher doses as a sacrament in religious… 
Safety of ibogaine administration in detoxification of opioid dependent individuals: a descriptive open-label observational study.
This open‐label observational study found that ibogaine treatment of patients with opioid use disorder can induce a clinically relevant but reversible QTc prolongation, bradycardia, and severe ataxia.
Ibogaine offers an alternative approach for treating opiate addiction
Ibogaine is a naturally occurring indole alkaloid that may be an effective alternative form of treatment for individuals struggling with opiate addiction and/or withdrawal and is found that iboga alkaloids such as ibogaine are effective at reducing morphine self-administration in rats.
hERG Blockade by Iboga Alkaloids
Results may relate to observations of persistent QT prolongation and cardiac arrhythmia at delayed intervals of days following ibogaine ingestion, and suggest that the iboga alkaloids might provide an informative paradigm for investigation of the structural biology of the hERG channel.